H7 Influenza Prime-Boost Regimens in Healthy Adults: Recombinant H7 DNA Plasmid Vaccine, VRC-FLUDNA071-00-VP, Administered Alone or With Monovalent Influenza Subunit Virion H7N9 Vaccine (MIV) as Prime With MIV Boost Compared to MIV Prime With MIV Boo...
Clinical trial NCT02206464 · COMPLETED
Trial details
- NCT number
- NCT02206464
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-29
- Primary completion
- 2016-01-07
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.